C 33 H 46 ClNO 5 S, orthorhombic, P2
Discussion
The title compound, ad erivative of pleuromutilin, was synthesized to be used as an antibiotic candidate to against someGrampositive bacteria. Pleuromutilin, was anatural drug and first isolated in ac rystalline form from cultures of two species of basidiomycetes, Pleurotus mutilus and P. passeckerianus in 1951 [1] .The pleuromutilins have received much investigative attention due to the high activities against drug-resistant Gram-positive bacteria and mycoplasmasinvitro and in vivo [2] , pharmacodynamic properties [3] and no target-specific cross-resistance to othera ntibiotics [4] . The molecular modifications of pleuromutilin were focused essentially on the C-14 glycolic acid chain, especially with athioether group and abasic group together [5] . Further alterations within this group led to the development of three drugs: tiamulin, valnemulin, and retapamulin. Footprinting analysis demonstrated that tiamulin and valnemulin are strong inhibitors of peptidyl transferase due to their interaction with domain Vof23S ribosomal RNA (rRNA) [6] .The title structure is built up of C 33 H 46 ClNO 5 Smolecules containing a5-6-8 tricyclic carbon skeleton and abenzene ring, in which all bond lengths are in normalranges. The synthesized side chain at C14 exhibits zigzag conformation. The torsion angles are -71.0(3)°and 75.2(3)°f or C21-S1-C22-C23 and S1-C22-C23-N1, respectively. The benzene ring is not coplanar with the amide bond and the dihedral angle between them is 81.06°. Six intramolecular H-bonds are formed among the molecules. Also, ther is one intermolecular Hbond (O1-H1···O5) linking the molecules to achain along [ (7) 0.0544(6) 0.0711 
